Routine use of Patient Concerns Inventory for head & neck cancer patients
Electronic versions
Description
Background
The consequences of treatment for Head and Neck cancer (HNC) patients has profound detrimental impacts such as impaired QOL, emotional distress, delayed recovery and frequent use of healthcare. The aim of this trial is to determine if the routine use of the Patients Concerns Inventory (PCI) package in review clinics during the first year following treatment can improve overall quality of life, reduce the social-emotional impact of cancer and reduce levels of distress. Furthermore, we aim to describe the economic costs and benefits of using the PCI.
The consequences of treatment for Head and Neck cancer (HNC) patients has profound detrimental impacts such as impaired QOL, emotional distress, delayed recovery and frequent use of healthcare. The aim of this trial is to determine if the routine use of the Patients Concerns Inventory (PCI) package in review clinics during the first year following treatment can improve overall quality of life, reduce the social-emotional impact of cancer and reduce levels of distress. Furthermore, we aim to describe the economic costs and benefits of using the PCI.
| Short title | Routine use of Patient Concerns Inventory for head & neck cancer patients |
|---|---|
| Status | Finished |
| Effective start/end date | 1/01/17 → 31/03/21 |
| Links | https://bmccancer.biomedcentral.com/track/pdf/10.1186/s12885-018-4355-0 |